15 July 2002
Ligands of the peroxisome proliferator-activated receptor-PPAR-α reduce myocardial infarct size
Nicole S. Wayman, Belinda L. Ellis, Christoph ThiemermannMed Sci Monit 2002; 8(7): BR243-247 :: ID: 13612
Abstract
Background: This study was designed to investigate the effects of two, chemically distinct activators of PPAR-α (clofibrate and WY14643) in a rat model of acute myocardial infarction.
Material/Methods: Male Wistar rats were anesthetized with sodium thiopentone (120 mg/kg i.v.) and subjected to regional myocardial ischemia (for 25 min) and reperfusion (for 2 h). Area at risk was determined by injection of Evans Blue dye and infarct size after staining with nitroblue tetrazolium.
Results: Pre-treatment of rats with the PPAR-α agonists clofibrate (0.3 mg/kg) caused a significant reduction in myocardial infarct size of 43%. Similarly, pre-treatment of rats with the PPAR-α agonists WY14643 (1 mg/kg) caused a significant reduction in myocardial infarct size of 43%.
Conclusions: Taken together, these results show that ligands of PPAR-α reduce the tissue necrosis associated with acute myocardial infarction. We propose that fibrates and other PPAR-α agonists
may be useful in conditions associated with ischemia-reperfusion of the heart and other organs.
Keywords: Cardiotonic Agents - pharmacology, Clofibrate - pharmacology, Heart - drug effects, Hemodynamic Processes, Ligands, Myocardial Infarction - metabolism, Myocardium - metabolism, Myocardium - pathology, Peroxisome Proliferators - pharmacology, Pyrimidines - pharmacology, Rats, Wistar, Receptors, Cytoplasmic and Nuclear - agonists, Receptors, Cytoplasmic and Nuclear - metabolism, Transcription Factors - agonists, Transcription Factors - metabolism
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952